期刊文献+

Association between Adiponectin and Metabolic Syndrome in Older Adults from Major Cities of China 被引量:4

Association between Adiponectin and Metabolic Syndrome in Older Adults from Major Cities of China
下载PDF
导出
摘要 Objective To investigate the association between adiponectin and metabolic syndrome (MetS) and related diseases in older adults from major cities of China. Methods A total of 2 049 adults at the age of 60-96 years from18 major cities of China were enrolled in the study. Plasma adiponectin and insulin concentrations were measured. Insulin resistance was assessed by homeostasis model assessment of insulin resistance (HOMA-IR). The definitions proposed by International Diabetes Federation (IDF) and American Heart Association/National Heart, Lung, and Blood/nstitute (AHA/NLHBI) were used to identify MetS. Results The adiponectin concentration increased with the advance of age and was higher in women than in men. The sex specific adiponectin concentration was inversely correlated with body mass index (BMI), waist circumference, diastolic blood pressure, triglycerides, glucose and fasting blood insulin, and positively correlated with HDL-C (P〈0.001). The adiponectin concentration decreased with increasing MetS components. Compared with the 4th sex-specific adiponectin quartile, the odds ratio (OR) for prevalent MetS-IDF and MetS-AHA/NLHBI in subjects of the 1st quartile group was 3.25 (95% CI: 2.24, 4.71) and 3.21 (95% CI: 2.26, 4.55), respectively. The association was independent of age, sex, life-style factors, medication, family history of chronic diseases, BMI, and HOMA-IR, The OR for MetS was much higher than those of MetS components and its related diseases. Conclusion Adiponectin is strongly associated with MetS independent of insulin resistance and obesity in older adults from major cities in China. The adiponectin concentration is a useful predictor for the risk of MetS. Objective To investigate the association between adiponectin and metabolic syndrome (MetS) and related diseases in older adults from major cities of China. Methods A total of 2 049 adults at the age of 60-96 years from18 major cities of China were enrolled in the study. Plasma adiponectin and insulin concentrations were measured. Insulin resistance was assessed by homeostasis model assessment of insulin resistance (HOMA-IR). The definitions proposed by International Diabetes Federation (IDF) and American Heart Association/National Heart, Lung, and Blood/nstitute (AHA/NLHBI) were used to identify MetS. Results The adiponectin concentration increased with the advance of age and was higher in women than in men. The sex specific adiponectin concentration was inversely correlated with body mass index (BMI), waist circumference, diastolic blood pressure, triglycerides, glucose and fasting blood insulin, and positively correlated with HDL-C (P〈0.001). The adiponectin concentration decreased with increasing MetS components. Compared with the 4th sex-specific adiponectin quartile, the odds ratio (OR) for prevalent MetS-IDF and MetS-AHA/NLHBI in subjects of the 1st quartile group was 3.25 (95% CI: 2.24, 4.71) and 3.21 (95% CI: 2.26, 4.55), respectively. The association was independent of age, sex, life-style factors, medication, family history of chronic diseases, BMI, and HOMA-IR, The OR for MetS was much higher than those of MetS components and its related diseases. Conclusion Adiponectin is strongly associated with MetS independent of insulin resistance and obesity in older adults from major cities in China. The adiponectin concentration is a useful predictor for the risk of MetS.
出处 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2010年第1期53-61,共9页 生物医学与环境科学(英文版)
基金 supported by the National Natural Science Foundation of China (30671750)
关键词 ADIPONECTIN Metabolic syndrome Chinese older adults OBESITY Insulin resistance Adiponectin Metabolic syndrome Chinese older adults Obesity Insulin resistance
  • 相关文献

参考文献44

  • 1Eckel R H, Grundy S M, Zimmet P Z (2005). The metabolic syndrome. Lancet 365, 1415-1428.
  • 2Cameron A J, Shaw J E, Zimmet P Z (2004). The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 33, 351-375.
  • 3Grundy S M, Cleeman J I, Daniels S R, et al. (2006). Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 21, 1-6.
  • 4Weyer C, Funahashi T, Tanaka S, et al. (2001). Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin EndocrinolMetab 86, 1930-1935.
  • 5Hotta K, Funahashi T, Bodkin N L, et al. (2001). Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 50, 1126-1133.
  • 6Berg A H, Combs T P, Du X, et al. (2001). The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7, 947-953.
  • 7Lindsay R S, Funahashi T, Hanson R L, et al. (2002). Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 360, 57-58.
  • 8Spranger J, Kroke A, Mohlig M, et al. (2003). Adiponectin and protection against type 2 diabetes mellitus. Lancet 361, 226-228.
  • 9Snehalatha C, Mukesh B, Simon M, et al. (2003). Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. Diabetes Care 26, 3226-3229.
  • 10Duncan B B, Schmidt M I, Pankow J S, et al. (2004). Adiponeetin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 53, 2473-2478.

同被引文献8

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部